A year after announcing its decision to exit stem cell therapy, Geron Corporation (GERN) announced that it has entered into a non-binding letter of intent (:LOI) with BioTime, Inc. (BTX) and BioTime`s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results